Showing results (231-240 of 2,686) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|April 30, 2015
Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysisPatrick G T Walker, Michael T White, Jamie T Griffin, et al.
The Lancet. Infectious Diseases|May 10, 2015
Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysisV Bhargavi Rao, Nur Johari, Philipp du Cros, et al.
The Lancet. Infectious Diseases|May 2, 2015
HIV rumbles on in the south of the USATalha Burki
The Lancet. Infectious Diseases|August 28, 2025
A transformation in cholera surveillanceAmanda K Debes, Erin T Baumgartner, Kendra N Williams, et al.
The Lancet. Infectious Diseases|September 6, 2025
Global policy responses to antimicrobial resistance, 2021-22: a systematic governance analysis of 161 countries and territoriesJay Patel, Sahar Saeedi Moghaddam, Sruthi Ranganathan, et al.
The Lancet. Infectious Diseases|August 30, 2025
Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in LeukaemiaMarie von Lilienfeld-Toal, Fareed Khawaja, Francesca Compagno, et al.
The Lancet. Infectious Diseases|August 15, 2016
The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysisHannah Alsdurf, Philip C Hill, Alberto Matteelli, et al.
The Lancet. Infectious Diseases|July 19, 2016
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational studyDilrini De Silva, Joanna Peters, Kevin Cole, et al.
The Lancet. Infectious Diseases|July 21, 2015
Corynebacterium ulcerans cutaneous diphtheriaLuke S P Moore, Asuka Leslie, Margie Meltzer, et al.
The Lancet. Infectious Diseases|July 24, 2015
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trialDavid A Margolis, Cynthia C Brinson, Graham H R Smith, et al.
Pageof 269